I am a
Home I AM A Search Login

Papers of the Week

2020 05 22



Aberrant subchondral osteoblastic metabolism modifies Na1.8 for osteoarthritis.


Zhu J, Zhen G, An S, Wang X, Wan M, Li Y, Chen Z, Guan Y, Dong X, Hu Y, Cao X
Elife. 2020 05 22; 9.
PMID: 32441256.


Pain is the most prominent symptom of osteoarthritis (OA) progression. However, the relationship between pain and OA progression remains largely unknown. Here we report osteoblast secret prostaglandin E2 (PGE2) during aberrant subchondral bone remodeling induces pain and OA progression in mice. Specific deletion of the major PGE2 producing enzyme cyclooxygenase 2 (COX2) in osteoblasts or PGE2 receptor EP4 in peripheral nerve markedly ameliorates OA symptoms. Mechanistically, PGE2 sensitizes dorsal root ganglia (DRG) neurons by modifying the voltage-gated sodium channel Na1.8, evidenced by that genetically or pharmacologically inhibiting Na1.8 in DRG neurons can substantially attenuate OA. Moreover, drugs targeting aberrant subchondral bone remodeling also attenuates OA through rebalancing PGE2 production and Na1.8 modification. Thus, aberrant subchondral remodeling induced Na1.8 neuronal modification is an important player in OA and is a potential therapeutic target in multiple skeletal degenerative diseases.